EP3685783
Unitary patentENDOLUMINAL LASER ABLATION DEVICE FOR TREATING VEINS
Hover an owner to see their dates
- biolitec Holding GmbH & Co. KGsince Jul 5, 2024
- biolitec Unternehmensbeteiligungs II AGJun 26, 2020 – Jul 5, 2024
An improved method and device are provided for safe and efficient low power density endoluminal treatment of venous insufficiency. One such device emits pulsed or continuous energy radially through an optical fiber end with a conical shaped tip for 360° radial emission. In some embodiments, a conical reflective surface is distally spaced opposite to and faces the emitting tip for enhancing radial emission efficiency by reflecting out any designed or remnant forwardly transmitted energy in radial directions. Other devices include flat emitting faces sealed within protective, radiation transparent covers. Laser radiation is transmitted at a wavelength and power such that is it substantially entirely absorbed within the blood vessel wall to sufficiently damage the intravascular endothelium and, in turn, achieve blood vessel closure. Because the energy is substantially entirely absorbed within the blood vessel wall, the need for a local anesthetic along the treatment area of the blood vessel may be substantially avoided.
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| Aug 13, 2026 | UPC CFI 256/2025 | Dusseldorf LD | Generic | Locked | S.I.A. LIGHTGUIDE International +2 |
Additional proceedings on this patent